Kellogg/WHU-08

Andreas Meudt was recently promoted to global R&D director of Archimica, formerly part of Clariant and now owned by private equity firm TowerBrook Capital Partners. It focuses on the supply of active pharmaceutical intermediates and advanced intermediates for the pharmaceutical industry.